Aenova Appoints Hanno Scheffczik as Managing Director of its Marburg Site

Hanno Scheffczik has been appointed as the new Managing Director of Temmler Pharma, a member of the Aenova Group. Effective Mar. 1, 2023, he succeeds Alfred Veit, who is retiring.

With around 150 employees, the Aenova site in Marburg manufactures delayed-release tablets and capsules as well as moisture-sensitive dosage forms.

Scheffczik studied chemistry with a focus on biochemistry and earned his doctorate at the Institute of Virology at Philipps University in Marburg. After holding various development and management positions at international research-based pharmaceutical companies, he joined Aenova in 2021, initially as Head of Manufacturing Science & Technology.

"With Dr. Scheffczik we have a long-standing experienced manager and expert who knows the industry and Aenova very well," commented Jan Kengelbach, CEO of Aenova.

Hanno Scheffczik, Managing Director, Temmler Pharma (a member of the Aenova...
Hanno Scheffczik, Managing Director, Temmler Pharma (a member of the Aenova Group). Source: Aenova Group

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.